The ability to measure the binding of a compound to its intended target in live cells or tissue is a critical parameter for drug discovery. A new method using polarized light microscopy adds to the current toolbox by enabling monitoring of target engagement in vitro and in vivo at single-cell resolution.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes
Nature Communications Open Access 19 May 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Bunnage, M.E., Chekler, E.L.P. & Jones, L.H. Nat. Chem. Biol. 9, 195–199 (2013).
Cook, D. et al. Nat. Rev. Drug Discov. 13, 419–431 (2014).
Dubach, J.M. Nat. Chem. Biol. 13, 168–173 (2017).
Schürmann, M., Janning, P., Ziegler, S. & Waldmann, H. Cell Chem. Biol. 23, 435–441 (2016).
Martinez Molina, D. et al. Science 341, 84–87 (2013).
Reinhard, F.B.M. et al. Nat. Methods 12, 1129–1131 (2015).
Huber, K.V.M. et al. Nat. Methods 12, 1055–1057 (2015).
Savitski, M.M. et al. Science 346, 1255784 (2014).
Snijder, B. et al. Nature 461, 520–523 (2009).
Thurber, G.M. et al. Nat. Commun. 4, 1504 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Huber, K. Shining a light. Nat Chem Biol 13, 133–134 (2017). https://doi.org/10.1038/nchembio.2295
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2295
This article is cited by
-
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes
Nature Communications (2023)